Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06854198 · ClinicalTrials.gov registry record · NA
Glaucoma Screening to Enhance At-Risk Californians' Health
A NA study, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 2,000
- Enrollment target
NCT06854198: Recruiting NA study, sponsored by University of California, San Francisco.
NCT06854198 is a NA study that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 2,000 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06854198, a NA study, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,000 participants
- Enrollment target
Study Summary
The vast majority of glaucoma cases in the United States go undetected and untreated until the late stages of the disease. Open-angle glaucoma is a progressive condition that is asymptomatic in its early to moderate stages and may be amenable to screening through telemedicine-based approaches. This study is a randomized trial to evaluate whether glaucoma screening with established tests (e.g., optical coherence tomography, fundus photography, and tonometry) is more effective for detecting undiagnosed glaucoma cases compared to education alone or delayed intervention.
Interventions
- OTHER Educational Brochure
- OTHER Glaucoma screening with optical coherence tomography (OCT), color fundus photography, and tonometry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2026-02-10 |
| Est. Completion | 2029-09 |
| Phase | NA |
What NCT06854198 shows while recruiting
NCT06854198 is an interventional study that assigns participants to a tested intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% higher).
The record links to 0 conditions, and to 2 interventions - of which Educational Brochure is the first listed.
NCT06854198 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06854198 about?
NCT06854198 is a clinical study titled "Glaucoma Screening to Enhance At-Risk Californians' Health". The vast majority of glaucoma cases in the United States go undetected and untreated until the late stages of the disease. Open-angle glaucoma is a progressive condition that is asymptomatic in its early to moderate stages and may be amenable to screening through telemedicine-based approaches. This ...
What is the current status of trial NCT06854198?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,000 participants. The study started on 2026-02-10. Estimated completion is 2029-09.
What interventions are being tested in trial NCT06854198?
The interventions under investigation include: Educational Brochure (OTHER), Glaucoma screening with optical coherence tomography (OCT), color fundus photography, and tonometry (OTHER).
Who is sponsoring clinical trial NCT06854198?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06854198's enrollment target sits among peer trials
2,000 52nd of 2000 higher than 1,947 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI